LenioBio

On my way to Boston for #PEGSBoston 2026 🚀 Join me tomorrow for my talk: 📍 From AI Designs to Oncology Leads in Days — Screening and Scaling Antibodies and RTKs with ALiCE® We'll cover how we used ALiCE HTPE to rapidly screen de novo GBM checkpoint VHHs, identify functional PD-L1 binders, and — for the first time anywhere — express a full-length RTK fusion recombinantly. From AI-designed sequences to functional oncology leads in three weeks. No cell-based bottlenecks. No expression restarts. Also presenting Poster B064 (Tuesday–Wednesday) on Lab-in-the-Loop expression with ALiCE HTPE. Find us at booth #820 — happy to talk hard targets, de novo sequences, and what ALiCE can unlock for your program. #PEGSSummit #LenioBio #DTE #CellFree

Excited to announce that LenioBio has entered into a collaboration with Twist Bioscience, bringing together Twist's DNA manufacturing and automation capabilities with our ALiCE® cell-free protein expression platform. The goal: close the gap between computational protein design and real-world biology. AI can design new drug molecules, but models only improve when they're fed high-quality, rapidly generated experimental data. This collaboration is built to make that feedback loop as fast as possible. With ALiCE® delivering full-length, folded, functional proteins within 24 hours, teams working in AI-driven antibody and biologic discovery can access faster, higher-throughput lab-in-the-loop cycles — without the expression bottlenecks that slow model iteration. Full details in the press release attached. 📩 If your organisation is working on AI-enabled drug discovery and wants to learn more about what we can offer, we'd love to hear from you. Get in touch.

DBT 2026 complete! ✅ If you missed the panel discussion "Difficult to Make Biologics" with our Head of R&D Jonathan Fauerbach (PhD, MBA), get in touch to book a follow up call!

🚨 New Publication Alert! 🚨 Congratulations to Jorge Armero Giménez and team for their new publication demonstrating the incorporation of non-canonical amino acids into VLPs with our ALiCE expression platform. Non-canonical amino acids are showing great promise for the next generation of conjugated therapeutics, and ALiCE allows you to move towards a "one pot" synthesis of these complex molecules. If you're interested in learning more, Jorge and colleagues are waiting to support you!

Less than one month to go for PEGS Boston 2026! Stop by booth #820 to meet our onsite team: Remberto Martis - Founder & Managing Director Jonathan Fauerbach (PhD, MBA) - Head of R&D Mark Fitzgerald - Strategic Account Lead - US Desmond Schofield - Head of Business Development See you there! #PEGS2026 #PEGSummit

Protein expression shouldn't be your bottleneck. We've made that message clearer than ever. leniobio.com just got a full refresh — cleaner design, simpler navigation, and everything you need to put ALiCE® to work on your next discovery. See what’s new 👉 leniobio.com #LenioBio #ALiCE #ProteinExpression #Biotech #AI

Some great talks so far at #PepTalk2026 and #TheBiologicSummit, and interesting to see the trend in key pain points being discussed… -         AI design iterations are stuck waiting for wet lab data -         Expressions fail late, after weeks of work -         Complex proteins don’t fold -         Toxic proteins kill their hosts -         Host system switching adds variability If you’re facing any of these challenges, we should spend 5 minutes talking about ALiCE, our protein expression platform which delivers full length, folded, and functional protein in 24 hours. Drop me a message here, or stop by booth 107 if you are in town!

🧬 If your discovery workflows depend on rapid protein expression, let’s talk. LenioBio will be at the PepTalk & BioLogic Summit 2026 in San Diego next week. Whether you’re supporting multiple programs, scaling AI-driven design, or building a new discovery platform, protein expression speed often sets the pace. 🤝 Meet us at Booth 107 to discuss how cell-free, eukaryotic expression can remove expression bottlenecks early in discovery ⚡ Our ALiCE® HTPE platform is designed for teams working with complex, AI-generated and difficult-to-express proteins: ✅ Full-length, folded, functional proteins in 24 hours ✅ Built for complex and AI-designed proteins ✅ Faster Design-Build-Test-Learn cycles 📍 Connect with our team members at Booth 107 🤝 Jonathan Fauerbach (PhD, MBA) | Desmond Schofield | Mark Fitzgerald DM or drop us an email if you want to connect with us before the event: sales@leniobio.com 🎤 Join one of our sessions: At PepTalk Track: Predictive Protein Production 📅 Monday, January 19 ⏰ 10:30 am At BioLogic Summit Track: ML/AI for BioLogics Developability, Optimization, and de novo Design 📅 Wednesday, January 21 ⏰ 9:50 am See you there! #PepTalk2026 #BioLogicSummit2026 #ALiCEplatform #RapidDiscovery #designbuildtestlearn #AIdrivendesign #ALiCEHTPE #eukaryoticexpression #proteinexpression #deNovoDesign #AIgeneratedproteins

🤖 AI can design thousands of protein variants, but the real bottleneck is testing them. At the PepTalk & BioLogic Summit 2026 in San Diego from January 19–22, LenioBio will share how to close the gap between in silico design and experimental validation. 🧬⚡Our ALiCE® HTPE Platform is built for discovery teams working with complex, AI-generated, and difficult-to-express proteins, enabling rapid lab-in-the-loop workflows. For teams navigating high-throughput discovery, AI-designed sequence libraries and complex targets, we’ll be sharing practical ways to move from design to data faster. ✅ Functional, full-length, properly folded proteins in 24 hours ✅ Faster Design-Build-Test-Learn cycles for early discovery ✅ Designed for complex and AI-generated proteins 🎤 Join one of the sessions by our Head of R&D, Jonathan Fauerbach: At PepTalk Track: Predictive Protein Production 📅 Monday, January 19 ⏰ 10:30 am At BioLogic Summit Track: ML/AI for BioLogics Developability, Optimization, and de novo Design 📅 Wednesday, January 21 ⏰ 9:50 am 📍Also, connect with our team at Booth 107: Desmond Schofield and Mark Fitzgerald #PepTalk #BioLogicSummit #ALiCEHTPE #CellFreeProteinExpression #complexproteins #labintheloop #highthroughputdiscovery #designtofunctionaldata #earlydiscovery #AIproteinvariants #AIforBioLogics #CROpartnerships

🎆✨ Welcome 2026! We’re energized to keep advancing protein science together with our partners and the wider research community 🤝 🎯 This year, our focus remains on strengthening cell-free protein expression as a platform that supports diverse approaches in protein discovery and development. By removing expression bottlenecks and enabling rapid evaluation of candidates, we will continue to help Biopharma, CDMO and academic teams reach key milestones faster and make confident decisions earlier in development 📈 🔬✨ We’re looking forward to a year of meaningful collaboration, ambitious research goals and proteins that push science forward. Get in touch with us: sales@leniobio.com #Welcome2026 #NewYear #ProteinScience #Partnerships #CellFreeExpression #ProteinDiscovery #Biopharma